Arup Bhattacharya, Ph.D.
Affiliations: | 2005 | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Medical Biophysics, OncologyGoogle:
"Arup Bhattacharya"Mean distance: (not calculated yet)
Parents
Sign in to add mentorRichard Mazurchuk | grad student | 2005 | SUNY Buffalo | |
(Non-invasive in vivo assessment of tumor hypoxia using functional magnetic resonance (fMR) imaging during therapy in human head and neck squamous cell carcinoma (HNSCC) xenografts: Implications for assessing therapeutic efficacy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yang L, Li Y, Bhattacharya A, et al. (2019) A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer. Science Translational Medicine. 11 |
Rustum YM, Chintala S, Durrani FA, et al. (2018) Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy. International Journal of Molecular Sciences. 19 |
Zakharia Y, Bhattacharya A, Rustum YM. (2018) Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development. Oncotarget. 9: 10765-10783 |
Yang L, Li Y, Bhattacharya A, et al. (2018) Abstract 552: PEPD is an essential regulator of p53 tumor suppressor Cancer Research. 78: 552-552 |
Yang L, Li Y, Bhattacharya A, et al. (2016) Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D. Oncotarget |
Veeranki OL, Bhattacharya A, Tang L, et al. (2015) Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer. Current Pharmacology Reports. 1: 272-282 |
Yang L, Li Y, Bhattacharya A, et al. (2015) Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant. Ebiomedicine. 2: 396-405 |
Yang L, Li Y, Bhattacharya A, et al. (2015) Abstract P6-07-04: Targeting ErbB2 with human PEPD Cancer Research. 75 |
Bhattacharya A, Li Y, Shi Y, et al. (2013) Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination. Carcinogenesis. 34: 2593-9 |
Bhattacharya A, Li Y, Geng F, et al. (2012) The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer. Carcinogenesis. 33: 394-8 |